Van Lanschot Kempen Logo
  • Home
  • Solutions
  • News & knowledge
  • About us
Nov 2015
Joint Bookrunner
€ 13.5 million
Private Placement


Probiodrug is a biopharmaceutical company dedicated to the research and development of novel therapeutic solutions to treat people with Alzheimer’s Disease

  • Probiodrug completed a sub-10% private placement by issuing new shares priced at market levels
  • Proceeds will be used for the preparations of further clinical development of its lead product PQ912
  • Kempen & Co’s efforts resulted in a well-covered book made up of long-term specialist investors

Fully focused on your future

Private Banking

  • Offices
  • Business professionals
  • Executives
  • Doctors
  • Entrepreneurs
  • Wealth management
  • Conditions
  • Private Banking - Belgium
  • Private Banking - Switzerland

Professional Solutions

Investment Management

Investment Banking

© Van Lanschot Kempen 2023
Privacy & cookies